NewsBenzinga애보트, ESMO 학회에서 새로운 베타-CORRECT 데이터 발표···수술 후 2년 내 대장암 재발 민감도 30% 향상 애보트, ESMO 학회에서 새로운 베타-CORRECT 데이터 발표···수술 후 2년 내 대장암 재발 민감도 30% 향상 Benzinga 2026.10.23 13:17 (GMT+0) Open on Benzinga Other news Mark Cuban Says AI Agents Can Be Like ‘Cockroaches’ That Find Ways Into Systems, But Defenders Can Fight Back With AI: ‘We’ve Always Had Hacks’ Nucor Has What It Takes To Capitalize On The Tailwinds In The Steel Market. (NYSE:NUE) Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis Transcript China Is Winning Tomorrow, But Losing Today Cathay General Bancorp Stock: Strong ROE Loan Re-Pricing In A Higher Rate (NASDAQ:CATY) Hercules Capital Stock: Close To A Buy, But Not Before 3Q26 (NYSE:HTGC)
Mark Cuban Says AI Agents Can Be Like ‘Cockroaches’ That Find Ways Into Systems, But Defenders Can Fight Back With AI: ‘We’ve Always Had Hacks’
Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis Transcript
